Molecular determinants that mediate selective activation of p38 MAP kinase isoforms

被引:187
|
作者
Enslen, H
Brancho, DM
Davis, RJ [1 ]
机构
[1] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA
来源
EMBO JOURNAL | 2000年 / 19卷 / 06期
关键词
MAP kinase; MKK3; MKK6; p38; signal transduction;
D O I
10.1093/emboj/19.6.1301
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p38 mitogen-activated protein kinase (MAPK) group is represented by four isoforms in mammals (p38 alpha, p38 beta 2, p38 gamma and p38 delta), These p38 MAPK isoforms appear to mediate distinct functions in vivo due, in part, to differences in substrate phosphorylation by individual p38 MAPKs and also to selective activation by MAPK kinases (MAPKKs), Here we report the identification of two factors that contribute to the specificity of p38 MAPK activation. One mechanism of specificity is the selective formation of functional complexes between MAPKK and different p38 MAPKs, The formation of these complexes requires the presence of a MAPK docking site in the N-terminus of the MAPKK. The second mechanism that confers signaling specificity is the selective recognition of the activation loop (T-loop) of p38 MAPK isoforms. Together, these processes provide a mechanism that enables the selective activation of p38 MAPK in response to activated MAPKK.
引用
收藏
页码:1301 / 1311
页数:11
相关论文
共 50 条
  • [41] p38 MAP kinase pathway regulates [GSH]
    Xiu, M
    Huang, CY
    Paulson, KE
    FASEB JOURNAL, 2000, 14 (08): : A1454 - A1454
  • [42] Novel inhibitors of p38 MAP kinase.
    Shetty, R
    Moffett, KK
    Nguyen, D
    Kelly, MJ
    Michelotti, EL
    Dorsey, BD
    Springman, E
    Bukhtiyarova, M
    Northrop, K
    Chai, XM
    Saporito, MS
    Ochman, AR
    Karpusas, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
  • [43] Osteoblastic cell differentiation and p38 MAP kinase
    Dziak, R
    Dahman, M
    Lampasso, J
    BONE, 2005, 36 : S287 - S287
  • [44] Cytokines, p38 MAP Kinase and the Pathophysiology of Depression
    Andrew H Miller
    Charles L Raison
    Neuropsychopharmacology, 2006, 31 : 2089 - 2090
  • [45] Benzothiazole based inhibitors of p38α MAP kinase
    Liu, Chunjian
    Lin, James
    Pitt, Sidney
    Zhang, Rosemary F.
    Sack, John S.
    Kiefer, Susan E.
    Kish, Kevin
    Doweyko, Arthur M.
    Zhang, Hongjian
    Marathe, Punit H.
    Trzaskos, James
    Mckinnon, Murray
    Dodd, John H.
    Barrish, Joel C.
    Schieven, Gary L.
    Leftheris, Katerina
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 1874 - 1879
  • [46] Imidazopyrimidines, potent inhibitors of p38 MAP kinase
    Rupert, KC
    Henry, JR
    Dodd, JH
    Wadsworth, SA
    Cavender, DE
    Olini, GC
    Fahmy, B
    Siekierka, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 347 - 350
  • [47] Synthesis of a naphthyridone p38 MAP kinase inhibitor
    Chung, John Y. L.
    Cvetovich, Raymond J.
    McLaughlin, Mark
    Amato, Joseph
    Tsay, Fuh-Rong
    Jensen, Mark
    Weissman, Steve
    Zewge, Daniel
    JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (22): : 8602 - 8609
  • [48] P38 MAP kinase inhibitors for the treatment of arthritis
    Barlocco, D
    Langston, S
    DRUG DISCOVERY TODAY, 2001, 6 (15) : 808 - 809
  • [49] Role of p38 MAP kinase in myocardial stress
    Nagarkatti, DS
    Sha'afi, RI
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (08) : 1651 - 1664
  • [50] Practical Synthesis of a p38 MAP Kinase Inhibitor
    Achmatowicz, Michal
    Thiel, Oliver R.
    Wheeler, Philip
    Bernard, Charles
    Huang, Jinkun
    Larsen, Robert D.
    Faul, Margaret M.
    JOURNAL OF ORGANIC CHEMISTRY, 2009, 74 (02): : 795 - 809